Recurrent TIPS failure associated with biliary fistulae: treatment with PTFE-covered stents

Cardiovasc Intervent Radiol. 1999 Jul-Aug;22(4):298-304. doi: 10.1007/s002709900392.

Abstract

Purpose: To evaluate the efficacy of covered stents for the treatment of transjugular intrahepatic portosystemic shunt (TIPS) obstruction in human subjects with identified or suspected biliary fistulae.

Methods: Five patients were treated for early failure of TIPS revisions. All had mid-shunt thrombus, and four of these had demonstrable biliary fistulae. Three patients also propagated thrombus into the native portal venous system and required thrombolysis. TIPS were revised in four patients using a custom-made polytetrafluoroethylene (PTFE)-covered Wallstent, and in one patient using a custom-made PTFE-covered Gianturco Z-stent.

Results: All identified biliary fistulae were successfully sealed. All five patients maintained patency and function of the TIPS during follow-up ranging from 2 days to 21 months (mean 8.4 months). No patient has required additional revision. Thrombosis of the native portal venous system was treated with partial success by mechanical thrombolysis.

Conclusion: Early and recurrent failure of TIPS with mid-shunt thrombosis, which may be associated with biliary fistulae, can be successfully treated using covered stents. Stent-graft revision appears to be safe, effective, and potentially durable.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Biliary Fistula / diagnostic imaging
  • Biliary Fistula / etiology
  • Biliary Fistula / therapy*
  • Child
  • Coated Materials, Biocompatible
  • Esophageal and Gastric Varices / drug therapy
  • Esophageal and Gastric Varices / surgery
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Follow-Up Studies
  • Gastrointestinal Hemorrhage / drug therapy
  • Gastrointestinal Hemorrhage / surgery
  • Humans
  • Male
  • Middle Aged
  • Polytetrafluoroethylene*
  • Portal Vein / diagnostic imaging
  • Portal Vein / pathology
  • Portasystemic Shunt, Transjugular Intrahepatic / adverse effects*
  • Radiography
  • Recurrence
  • Retrospective Studies
  • Safety
  • Stents*
  • Thrombolytic Therapy
  • Treatment Outcome
  • Ultrasonography, Doppler

Substances

  • Coated Materials, Biocompatible
  • Fibrinolytic Agents
  • Polytetrafluoroethylene